Q92968 (PEX13_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Peroxisomal membrane protein PEX13 Alternative name(s): Peroxin-13 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 403 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Component of the peroxisomal translocation machinery with PEX14 and PEX17. Functions as a docking factor for the predominantly cytoplasmic PTS1 receptor (PAS10/PEX5). Involved in the import of PTS1 and PTS2 proteins. |
| Subunit structure | |
| Subcellular location | |
| Involvement in disease | Peroxisome biogenesis disorder complementation group 13 (PBD-CG13) [MIM:614883]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). Peroxisome biogenesis disorder 11A (PBD11A) [MIM:614883]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. Peroxisome biogenesis disorder 11B (PBD11B) [MIM:614885]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. |
| Sequence similarities | Belongs to the peroxin-13 family. Contains 1 SH3 domain. |
| Caution | It is uncertain whether Met-1 or Met-40 is the initiator. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PEX19 | P40855 | 2 | EBI-594849,EBI-594747 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 403 | 403 | Peroxisomal membrane protein PEX13 | PRO_0000058323 | |||||
Regions | |||||||||
| Topological domain | 1 – 226 | 226 | Lumenal Potential | ||||||
| Transmembrane | 227 – 251 | 25 | Helical; Potential | ||||||
| Topological domain | 252 – 403 | 152 | Cytoplasmic Potential | ||||||
| Domain | 276 – 334 | 59 | SH3 | ||||||
| Region | 145 – 233 | 89 | Targeting to peroxisomes | ||||||
| Region | 175 – 196 | 22 | Interaction with PEX19 | ||||||
| Compositional bias | 5 – 11 | 7 | Poly-Pro | ||||||
Natural variations | |||||||||
| Natural variant | 326 | 1 | I → T in PBD11B; neonatal adrenoleukodystrophy. Ref.10 Ref.11 | VAR_009306 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a human PTS1 receptor docking protein directly required for peroxisomal protein import." Fransen M., Terlecky S.R., Subramani S. Proc. Natl. Acad. Sci. U.S.A. 95:8087-8092(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Isolation, characterization and mutation analysis of PEX13-defective Chinese hamster ovary cell mutants." Toyama R., Mukai S., Itagaki A., Tamura S., Shimozawa N., Suzuki Y., Kondo N., Wanders R.J., Fujiki Y. Hum. Mol. Genet. 8:1673-1681(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Trachea. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Liver. |
| [6] | "Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTs1 receptor." Gould S.J., Kalish J.E., Morrell J.C., Bjoerkman J., Urquhart A.J., Crane D.I. J. Cell Biol. 135:85-95(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 40-403. |
| [7] | "PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis." Sacksteder K.A., Jones J.M., South S.T., Li X., Liu Y., Gould S.J. J. Cell Biol. 148:931-944(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PEX19. |
| [8] | "Human pex19p binds peroxisomal integral membrane proteins at regions distinct from their sorting sequences." Fransen M., Wylin T., Brees C., Mannaerts G.P., Van Veldhoven P.P. Mol. Cell. Biol. 21:4413-4424(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PEX19, SUBCELLULAR LOCATION. |
| [9] | "Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations." Al-Dirbashi O.Y., Shaheen R., Al-Sayed M., Al-Dosari M., Makhseed N., Abu Safieh L., Santa T., Meyer B.F., Shimozawa N., Alkuraya F.S. Am. J. Med. Genet. A 149:1219-1223(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN PBD11A. |
| [10] | "PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders." Liu Y., Bjoerkman J., Urquhart A., Wanders R.J.A., Crane D.I., Gould S.J. Am. J. Hum. Genet. 65:621-634(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PBD11B THR-326. |
| [11] | "Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders." Shimozawa N., Suzuki Y., Zhang Z., Imamura A., Toyama R., Mukai S., Fujiki Y., Tsukamoto T., Osumi T., Orii T., Wanders R.J.A., Kondo N. Hum. Mol. Genet. 8:1077-1083(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN PBD11A, VARIANT PBD11B THR-326. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF048755 mRNA. Translation: AAC39844.1. AB022192 mRNA. Translation: BAA88907.1. AK315244 mRNA. Translation: BAG37668.1. CH471053 Genomic DNA. Translation: EAX00018.1. BC067090 mRNA. Translation: AAH67090.1. U71374 mRNA. Translation: AAD05572.1. |
| IPI | IPI00024348. |
| RefSeq | NP_002609.1. NM_002618.3. |
| UniGene | Hs.161377. |
3D structure databases | |
| ProteinModelPortal | Q92968. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q92968. 4 interactions. |
| MINT | MINT-241563. |
| STRING | 9606.ENSP00000295030. |
Protein family/group databases | |
| TCDB | 3.A.20.1.1. peroxisomal protein importer (PPI) family. |
PTM databases | |
| PhosphoSite | Q92968. |
Polymorphism databases | |
| DMDM | 3914319. |
Proteomic databases | |
| PaxDb | Q92968. |
| PRIDE | Q92968. |
Protocols and materials databases | |
| DNASU | 5194. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000295030; ENSP00000295030; ENSG00000162928. |
| GeneID | 5194. |
| KEGG | hsa:5194. |
| UCSC | uc002sau.4. human. |
Organism-specific databases | |
| CTD | 5194. |
| GeneCards | GC02P061244. |
| HGNC | HGNC:8855. PEX13. |
| HPA | HPA032142. |
| MIM | 601789. gene. 614883. phenotype. 614885. phenotype. |
| neXtProt | NX_Q92968. |
| Orphanet | 772. Infantile Refsum disease. 44. Neonatal adrenoleukodystrophy. 912. Zellweger syndrome. |
| PharmGKB | PA33197. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG281515. |
| HOGENOM | HOG000231374. |
| HOVERGEN | HBG053570. |
| InParanoid | Q92968. |
| KO | K13344. |
| OMA | YRRLQWM. |
| OrthoDB | EOG4VMFG3. |
| PhylomeDB | Q92968. |
Gene expression databases | |
| ArrayExpress | Q92968. |
| Bgee | Q92968. |
| CleanEx | HS_PEX13. |
| Genevestigator | Q92968. |
| GermOnline | ENSG00000162928. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR007223. Peroxin-13_N. IPR001452. SH3_domain. [Graphical view] |
| Pfam | PF04088. Peroxin-13_N. 1 hit. PF00018. SH3_1. 1 hit. [Graphical view] |
| PRINTS | PR00452. SH3DOMAIN. |
| SMART | SM00326. SH3. 1 hit. [Graphical view] |
| SUPFAM | SSF50044. SH3. 1 hit. |
| PROSITE | PS50002. SH3. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 5194. |
| NextBio | 20090. |
| SOURCE | Search... |
Entry information
| Entry name | PEX13_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92968 Secondary accession number(s): B2RCS1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
